A detailed history of Icw Investment Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Icw Investment Advisors LLC holds 526 shares of LLY stock, worth $417,717. This represents 0.2% of its overall portfolio holdings.

Number of Shares
526
Previous 483 8.9%
Holding current value
$417,717
Previous $437,000 6.64%
% of portfolio
0.2%
Previous 0.2%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $33,202 - $41,280
43 Added 8.9%
526 $466,000
Q2 2024

Aug 05, 2024

SELL
$724.87 - $909.04 $5,798 - $7,272
-8 Reduced 1.63%
483 $437,000
Q1 2024

May 09, 2024

BUY
$592.2 - $792.28 $40,269 - $53,875
68 Added 16.08%
491 $381,000
Q4 2023

Feb 05, 2024

BUY
$525.19 - $619.13 $19,957 - $23,526
38 Added 9.87%
423 $246,000
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $167,359 - $230,730
385 New
385 $206,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $755B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Icw Investment Advisors LLC Portfolio

Follow Icw Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Icw Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Icw Investment Advisors LLC with notifications on news.